OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

What has OWCP been doing instead of babysitting inpatient investors:

https://patentimages.storage.googleapis.com/8f/73/66/91ea24f64b0281/US20180042845A1.pdf

https://patentimages.storage.googleapis.com/2f/aa/58/aa80e19d0880d5/US20170367875A1.pdf

https://patentimages.storage.googleapis.com/b8/1c/09/45c55ac2ed6c11/US20180042890A1.pdf


Just last February 18, 2018, OWC Pharmaceutical Research Corp., OTCQB: OWCP, appointed Dr. Oron Yacoby Zeevi as its Chief Scientific Officer (CSO).

Dr. Oron Yacoby Zeevi, age 57, Chief Scientific Officer : Dr. Yacoby Zeevi has more than 20 years of extensive scientific experience with both private and publicly listed companies in the biopharmaceutical industry. In 2008, Dr. Yacoby Zeevi joined Neuroderm Ltd (Nasdaq: NDRM), a clinical-stage pharmaceutical company developing next-generation treatments for central nervous system (CNS) disorders as the Vice President of Research and was promoted to the position of VP R&D. From October 2016 until her recent departure, she served as Chief Scientific Officer of Neuroderm, which was sold to Mitsubishi Tanabe Pharma for US $1.1 billion in July 2017.

Common sense tells me that Dr. Zeevi wouldn't have joined OWCP if it was not a great opportunity for her to be part of another successful start-up.

Dr. Yacoby Zeevi, is the inventor of over 50 issued patents and patents pending, Her expertise lies in industry-oriented innovation and scientific research, accelerating and orchestrating the evolution of new ideas through R&D PoC, IP, CMC, early efficacy and safety trials, regulatory affairs and market landscape mapping in fields of unmet medical needs, towards development of commercially viable pharmaceutical or agricultural products. Dr. Yacobi Zeevi earned her PHD in micro biology and immunology from the Ben Gurion University of Be’er Sheva, Israel and also holds a degree of Doctor in Veterinary Medicine from the Hebrew University of Jerusalem

Dr. Yacoby Zeevi commented, "I am very proud to join OWCP and cooperate with their excellent management team in order to advance the Company to the next level. The Company has achieved a great deal in its clinical development to date and I am sure I can help in accelerating its growth."



Just last week we made an agreement for $5 Million in funding, and folks are getting all impatient again that they aren't receiving a daily update on the exact going ons of the OWC team in Israel. Do you guys want them to put out fluff that will only be called pumping, or do you want them to do their R&D and Patent work?




$OWCP Long and Strong... GOING TO BE HUGE!